A Study of Lazertinib (JNJ-73841937) in Healthy Participants
Clinical trial NCT05076877 · COMPLETED
Trial details
- NCT number
- NCT05076877
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-17
- Primary completion
- 2022-02-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.